The North America Alzheimer's Diagnosis and Drugs Market is gaining traction due to the rising incidence of Alzheimer's disease and increasing adoption of advanced diagnostic technologies and pharmaceutical therapies throughout the region. Market Overview The Alzheimers Diagnosis and Drugs market was valued at US$ 12.71 billion in 2025 and is expected to reach US$ 25.77 billion by 2034; it is...